Avidity Biosciences, Inc. (RNA) Debt to Equity (2019)
Avidity Biosciences' Debt to Equity history spans 1 years, with the latest figure at -$0.07 for Q4 2019.
- For Q4 2019, Debt to Equity changed N/A year-over-year to -$0.07; the TTM value through Dec 2019 reached -$0.07, changed N/A, while the annual FY2019 figure was -$0.07, N/A changed from the prior year.
- Debt to Equity reached -$0.07 in Q4 2019 per RNA's latest filing.
- In the past five years, Debt to Equity ranged from a high of -$0.07 in Q4 2019 to a low of -$0.07 in Q4 2019.